
Join the Immuno-Pathology Network for our first workshop on cancer immunology.
The workshop will take place in person at the Francis Crick Institute on Friday 4 March 2022. The workshop will be followed by drinks, nibbles and networking.
*Update: This event is now full*
The workshop is open to scientists, researchers, academics and clinicians who are working or interested in cancer immunology.
The session will be a friendly, fun afternoon with open discussion and the opportunity to get to know new colleagues, explore novel ideas and options for collaboration.
The goal of the Immuno-Pathology Network is to ensure effective communication between basic research scientists (e.g. biology, chemistry, physics, bioengineering, bioinformatics), clinicians and public health experts with an interest in immuno-pathology, working across Imperial College London and at its research partners (the Francis Crick Institute, the Institute for Cancer Research and the Wellcome Sanger Institute).
Talks will be given by a selection of excellent speakers (provisional schedule below) and will each run for 20 minutes followed by a 5 minute Q&A. The talks will be giving a flavour/insight into the kind of work going on across the Network.
- 13:00-13:05: Introduction / Welcome
- 13:05-13:30: Luis Zapata (ICR): Rise and fall of metastatic clones under immune attack
- 13:30-13:55: Cristina Lo Celso (Imperial): Dynamic regulation of hierarchical heterogeneity in Acute Myeloid Leukemia as a tumor immunoevasion mechanism
- 13:55-14:20: Caetano Reis e Sousa (Crick): DaNGeRous indigestion and immunity to cancer
- 14:20-14:45: Matt Fuchter (Imperial): Enabling Natural Killer Cell Immunotherapy of Cancer with Small Molecules
- 14:45-15:15: Tea Break / Networking
- 15:15-15:40: Guido Franzoso (Imperial): Cancer-selective targeting of the NF-κB transcription factor pathway
- 15:40-16:05: Anna Wilkins (ICR): The role of cancer-associated fibroblasts and the extracellular matrix in the tumour response to radiotherapy
- 16:05-16:30: Alice Agliano (Imperial): Bioengineering strategies for cancer
- 16:30-16:55: Ilaria Malanchi (Crick): The dark side of neutrophils’ healing power
- 16:55-17:00: Concluding comments
- 17:00: Drinks + nibbles / Networking
COVID-19 safety: Please note that all attendees must show evidence of a negative lateral flow test (LFT) taken on the day or a negative PCR within 72 hours of the event.